The multiomics market in China is expected to reach a projected revenue of US$ 510.0 million by 2033. A compound annual growth rate of 16.7% is expected of China multiomics market from 2026 to 2033.
In terms of revenue, China accounted for 4.7% of the global multiomics market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In Asia Pacific, China multiomics market is projected to lead the regional market in terms of revenue in 2033.
India is the fastest growing regional market in Asia Pacific and is projected to reach USD 346.3 million by 2033.
The growth of the biotechnology and pharmaceutical sectors significantly contributes to the expansion of the genomics market. Furthermore, as these industries advance, the biotechnology industry in China is expected to grow, resulting in an increased market share for genomics in the country.
The improving healthcare infrastructure and the rising healthcare expenditure by both pharmaceutical companies & the government are anticipated to propel the growth of multiomics market.
For instance, the National Genomics Data Center (NGDC) in China has been actively providing a suite of newly developed and regularly updated database resources to assist in managing the rapidly expanding pool of multiomics data.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Multiomics Market Outlook will help companies and investors design strategic landscapes.
Bulk Multiomics was the largest segment with a revenue share of 77.25% in 2025.
Horizon Databook has segmented the China multiomics market based on single-cell multiomics, bulk multiomics covering the revenue growth of each sub-segment from 2021 to 2033.
The growth of the biotechnology and pharmaceutical sectors significantly contributes to the expansion of the genomics market. Furthermore, as these industries advance, the biotechnology industry in China is expected to grow, resulting in an increased market share for genomics in the country.
The improving healthcare infrastructure and the rising healthcare expenditure by both pharmaceutical companies & the government are anticipated to propel the growth of multiomics market.
For instance, the National Genomics Data Center (NGDC) in China has been actively providing a suite of newly developed and regularly updated database resources to assist in managing the rapidly expanding pool of multiomics data.
China Multiomics Market Type Outlook (Revenue, USD Million , 2021-2033)
Single-cell Multiomics
Bulk Multiomics
China Multiomics Market Platform Outlook (Revenue, USD Million , 2021-2033)
Genomics
Transcriptomics
Proteomics
Metabolomics
Integrated Omics Platforms
China Multiomics Market Product & Service Outlook (Revenue, USD Million , 2021-2033)
Services
Product
China Multiomics Market End Use Outlook (Revenue, USD Million , 2021-2033)
Pharmaceutical & Biotechnology Companies
Others
Academic & Research Institutes
China Multiomics Market Application Outlook (Revenue, USD Million , 2021-2033)
Immunology
Cell Biology
Oncology
Neurology
Reasons to subscribe to Multiomics Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Multiomics Market Outlook databook
Our clientele includes a mix of Multiomics Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China Multiomics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into China Multiomics Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.